Back to Journals » International Journal of Women's Health » Volume 6

Vertical transmission of hepatitis B virus: challenges and solutions

Authors Gentile I, Borgia G

Received 28 February 2014

Accepted for publication 10 April 2014

Published 10 June 2014 Volume 2014:6 Pages 605—611

DOI https://doi.org/10.2147/IJWH.S51138

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3


Ivan Gentile, Guglielmo Borgia

Department of Clinical Medicine and Surgery, University of Naples “Federico II”, Naples, Italy

Abstract: More than 240 million people worldwide are chronically infected with hepatitis B virus (HBV). Mother-to-child transmission remains the most important mechanism of infection in countries with a high prevalence of HBV. Universal screening of all pregnant women, at-birth prophylaxis with specific anti-HBV immune globulin, as well as HBV vaccination for newborns of infected mothers are effective in reducing the risk of vertical transmission. However, in cases of a high viral load and hepatitis B e antigen positivity, there is a residual risk of HBV transmission to the newborn despite prophylaxis. This review focuses on the above-indicated strategies and on the efficacy and safety of antiviral drugs administered during the third trimester of pregnancy.

Keywords: immune globulin, prophylaxis, telbuvidine, tenofovir, vaccine, viral load

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]